Literature DB >> 8478077

Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host.

D Tavares1, A Salvador, P Ferreira, M Arala-Chaves.   

Abstract

A protein with an isoelectric point of 4.3 and a relative molecular mass of 43 kDa (p43) was purified from the supernatants of the cultures of pathogenic Candida albicans but could not be detected in the supernatants of cultures of this fungus with pathogenicity previously attenuated after being repeatedly subcultured in vitro. Treatment of BALB/c and C57BL/6 mice with p43 resulted in (i) marked increases in the numbers of splenic immunoglobulin-secreting plaque-forming cells (PFC) with peak responses of immunoglobulin M (IgM) PFC preceding those of IgG PFC, with an isotype restriction pattern of IgG2a > IgG2b > IgG3 > IgG1 > IgM, and (ii) specific immunosuppression of the murine primary immune response against sheep erythrocytes. Immunosuppressive and B-cell mitogenic properties of p43 were quantitatively associated and inversely correlated with susceptibility to C. albicans infection. C57BL/6 mice treated with p43 2 days before inoculation with C. albicans were considerably more susceptible to the fungal infection than untreated mice. The immunobiological and chemical properties of p43 are compared with previously described immunosuppressive and B-cell mitogenic proteins produced by bacteria and viruses, and strategies for immunointervention are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478077      PMCID: PMC280779          DOI: 10.1128/iai.61.5.1881-1888.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Antibody formation in mouse bone marrow. I. Evidence for the development of plaque-forming cells in situ.

Authors:  R Benner; F Meima; G M van der Meulen; W B van Muiswinkel
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

3.  Late onset chronic mucocutaneous candidiasis with lymphoma and specific serum inhibitory factor.

Authors:  I K Aronson; C H Rieger; K Soltani; V Tkalcevic; W C Chan; A L Lorincz; G Matz
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

4.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

5.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

6.  Fungal toxins as a parasitic factor responsible for the establishment of fungal infections.

Authors:  K Iwata
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

7.  Effect of systemic candidiasis on blastogenesis of lymphocytes from germfree and conventional rats.

Authors:  T J Rogers; E Balish
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

8.  Modulation of immune response by bacterial lipopolysaccharide (LPS): multifocal effects of LPS-induced suppression of the primary antibody response to a T-dependent antigen.

Authors:  T Uchiyama; D M Jacobs
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

9.  Effect of immunosuppression on the development of experimental hematogenous Candida endophthalmitis.

Authors:  D K Henderson; L J Hockey; L J Vukalcic; J E Edwards
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

10.  Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function.

Authors:  P Gatenby; A Basten; E Adams
Journal:  J Clin Lab Immunol       Date:  1980-05
View more
  8 in total

1.  Identification of NAD+ synthetase from Streptococcus sobrinus as a B-cell-stimulatory protein.

Authors:  Isabel Veiga-Malta; Margarida Duarte; Márcia Dinis; Pedro Madureira; Paula Ferreira; Arnaldo Videira
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

Review 2.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

3.  The biological effects induced in mice by p36, a proteinaceous factor of virulence produced by African swine fever virus, are mediated by interleukin-4 and also to a lesser extent by interleukin-10.

Authors:  M Vilanova; P Ferreira; A Ribeiro; M Arala-Chaves
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

Review 4.  Serologic response to cell wall mannoproteins and proteins of Candida albicans.

Authors:  J P Martínez; M L Gil; J L López-Ribot; W L Chaffin
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Mycobacteria-induced autoantibody production is associated with susceptibility to infection but not with host propensity to develop autoimmune disease.

Authors:  A Brás; A P Aguas
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

6.  Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.

Authors:  Manuel Vilanova; Luzia Teixeira; Iris Caramalho; Egídio Torrado; Andreia Marques; Pedro Madureira; Adília Ribeiro; Paula Ferreira; Miguel Gama; Jocelyne Demengeot
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

Review 7.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

8.  Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen.

Authors:  Marianne A Bryan; Karen A Norris
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.